» Articles » PMID: 2893206

Rapid Alkalinisation for Flavone Acetic Acid Administration: a Potentially Hazardous Procedure

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1988 Feb 20
PMID 2893206
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma.

Kaye S, Clavel M, Dodion P, Monfardini S, Wagener D, Gundersen S Invest New Drugs. 1990; 8 Suppl 1:S95-9.

PMID: 2380021 DOI: 10.1007/BF00171993.


Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid.

Ching L, McKeage M, Joseph W, Kestell P, Zwi L, Baguley B Cancer Chemother Pharmacol. 1991; 28(6):414-9.

PMID: 1934245 DOI: 10.1007/BF00685816.


Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice.

McKeage M, Kestell P, Denny W, Baguley B Cancer Chemother Pharmacol. 1991; 28(6):409-13.

PMID: 1934244 DOI: 10.1007/BF00685815.


Breast cancer screening as public health policy in Finland.

Hakama M, Elovainio L, Kajantie R, LOUHIVUORI K Br J Cancer. 1991; 64(5):962-4.

PMID: 1931626 PMC: 1977451. DOI: 10.1038/bjc.1991.436.


An evaluation of the putative human mammary tumour retrovirus associated with peripheral blood monocytes.

Kahl L, Carroll A, Rhodes P, Wood J, Read N Br J Cancer. 1991; 63(4):534-40.

PMID: 1708675 PMC: 1972346. DOI: 10.1038/bjc.1991.126.